Sight Sciences Inc (NAS:SGHT)

Q3 2025 Sight Sciences Inc Earnings Call Transcript

Nov 6, 2025 / 09:30 PM GMT

Release Date Price: $5 (-0.60%)

Transcript 10-Q8-K

Key Points

Positve

Sight Sciences Inc (SGHT) raised its full-year 2025 revenue guidance to $76 to $78 million, reflecting strong performance and confidence in future growth.
The company achieved significant advancements in its dry eye business, with new fee schedules established for its Tier Care system, potentially expanding market access.
Surgical glaucoma revenue increased by 6% compared to the third quarter of 2024, driven by increased ordering accounts and average selling prices.
Gross margin improved to 86%, up from 84% in the previous year, indicating better cost management and operational efficiency.
The company announced management changes, promoting Ali Bauerlein to Chief Operating Officer and Jim Rodberg to Chief Financial Officer, which is expected to strengthen operational execution and strategic focus.

Negative

Total revenue for the third quarter decreased by 1% compared to the same period in the prior year, indicating challenges in maintaining overall growth.
Dry eye revenue significantly decreased from $1.5 million to $0.2 million, reflecting a strategic shift but also highlighting current underperformance in this segment.
The company incurred $0.4 million in surgical glaucoma cost of goods sold associated with tariffs, impacting profitability.
Despite improvements, the company still reported a net loss of $8.2 million, although this was an improvement from the previous year's loss.
There is uncertainty regarding the timing of additional reimbursement coverage and payment decisions for Tier Care, which could impact future revenue growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SGHT.OQ - Sight Sciences Inc
Q3 2025 Sight Sciences Inc Earnings Call
Nov 06, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to Sight Sciences 3rd quarter 2025 earnings results conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press 11 on your telephone, and you'll then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again.

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Hannah Jeffrey, Investor Relations. Please go ahead.

------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.